OnKure Funding & Investors
OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.
onkuretherapeutics.comTotal Amount Raised: $117,649,184
OnKure Funding Rounds
Series C
$54,000,000
Series C Investors
Surveyor CapitalAcorn BioventuresCormorant Asset ManagementPerceptive AdvisorsDeep Track CapitalSamsara BioCapitalBlackRockSeries B
$56,649,181
Series B Investors
Acorn BioventuresCormorant Asset ManagementPerceptive AdvisorsSamsara BioCapitalSurveyor CapitalSeries A
$7,000,000
Series A Investors
Delian CapitalOnKure management
Funding info provided by Diffbot.